Id |
Description |
Lang |
Type |
Status |
Case? |
Module |
5025522016 |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
en |
Fully specified name |
Active |
Only initial character case insensitive (core metadata concept) |
SNOMED CT core |
5025523014 |
Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product |
en |
Synonym (core metadata concept) |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
5025524015 |
Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine |
en |
Synonym (core metadata concept) |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
5025522016 |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
en |
Fully specified name |
Active |
Only initial character case insensitive (core metadata concept) |
SNOMED CT core |
5025523014 |
Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product |
en |
Synonym (core metadata concept) |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
5025524015 |
Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine |
en |
Synonym (core metadata concept) |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
377751000195112 |
vaccino contro i papillomavirus umani 6, 11, 16, 18, 31, 33, 45, 52 e 58 |
it |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
3360861001000112 |
Impfstoff gegen humanes Papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 und 58 |
de |
Synonym (core metadata concept) |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
1137961000241119 |
vaccin contre le papillomavirus humain 6, 11, 16, 18, 31, 33, 45, 52 and 58 |
fr |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
4229341000241115 |
vaccin contenant seulement les antigènes des papillomavirus humains 6, 11, 16, 18, 31, 33, 45, 52 et 58 |
fr |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
1137961000241119 |
vaccin contre le papillomavirus humain 6, 11, 16, 18, 31, 33, 45, 52 and 58 |
fr |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
4229341000241115 |
vaccin contenant seulement les antigènes des papillomavirus humains 6, 11, 16, 18, 31, 33, 45, 52 et 58 |
fr |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
377751000195112 |
vaccino contro i papillomavirus umani 6, 11, 16, 18, 31, 33, 45, 52 e 58 |
it |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
3360861001000112 |
Impfstoff gegen humanes Papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 und 58 |
de |
Synonym (core metadata concept) |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
Is a |
Vaccine product containing only Human papillomavirus antigen (medicinal product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
Plays role |
Active immunity stimulant role (role) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Human papillomavirus 16 (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Human papillomavirus 18 (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Human papillomavirus 11 (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Human papillomavirus 31 (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Human papilloma virus 33 Ag |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Human papilloma virus 45 Ag |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Human papilloma virus 6 Ag |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
7 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Human papillomavirus 52 (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
8 |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Human papillomavirus 58 Ag |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
9 |
|